SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-286811
Filing Date
2020-11-05
Accepted
2020-11-05 16:03:45
Documents
52
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d946267d10q.htm   iXBRL 10-Q 1434206
2 EX-31.1 d946267dex311.htm EX-31.1 10378
3 EX-31.2 d946267dex312.htm EX-31.2 10392
4 EX-32.1 d946267dex321.htm EX-32.1 5136
  Complete submission text file 0001193125-20-286811.txt   5551834

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cbay-20200930.xsd EX-101.SCH 29946
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20200930_cal.xml EX-101.CAL 33401
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20200930_def.xml EX-101.DEF 144014
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20200930_lab.xml EX-101.LAB 272724
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20200930_pre.xml EX-101.PRE 210851
10 EXTRACTED XBRL INSTANCE DOCUMENT d946267d10q_htm.xml XML 1123488
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 201290371
SIC: 2834 Pharmaceutical Preparations